https://doi.org/10.1056/NEJMoa2517384
5d ago
Phase 3 trial: Mim8, a bispecific antibody for hemophilia A (± inhibitors). Patients ≥12 received weekly/monthly doses based on weight. PMID:42054679, N Engl J Med 2026, @NEJM https://doi.org/10.1056/NEJMoa2517384 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
You might also wanna read
Uber Chooses Munich as AI Robotaxi Testing Ground
on.wsj.com·16m ago
Tesla registrations in Sweden rise 71% year-on-year in May
reut.rs·22m ago
The jobs apocalypse: a (very) short history
econ.st·23m ago
The Exclusive Retreat Where Wealthy Kids Learn How Not to Blow an Inheritance
on.wsj.com·23m ago
AI-Driven Layoffs Create Unrecognized Grief Crisis Among Tech Workers
The article examines the psychological and emotional toll of AI-driven job displacement on tech workers, arguing that the experience closely
jackmaguire.org·23m agoAutonomous Agentic Systems: A Practical Guide to "Always-On" Agents
hackernoon.com·24m ago